SUBSCRIBERS
Trendlines sells ApiFix stake in its largest exit since IPO
Vivienne Tay
Published Thu, Apr 2, 2020 · 09:50 PM
Singapore
CATALIST-LISTED startup incubator The Trendlines Group has sold its 18.62 per cent stake in ApiFix, a scoliosis treatment company, to Nasdaq-listed OrthoPediatrics.
This marks Trendlines' largest exit by value since its initial public offering in 2015. Its second-largest exit was ETView in 2016.
Decoding Asia newsletter: your guide to navigating Asia in a new global order. Sign up here to get Decoding Asia newsletter. Delivered to your inbox. Free.
Copyright SPH Media. All rights reserved.